U.S. pharmaceutical giant Pfizer is to offer its pneumonia vaccine at a much lower price to NGOs working on humanitarian crises.
The drug company said a new multidose version of its Prevenar 13 vaccine will be available at $3.10 per dose, the “lowest prevailing global” price, to select groups working in emergency settings, starting early next year. In the meantime, Pfizer will offer free single-dose vials of the drug to NGOs to address immediate needs for the vaccine in disaster settings.
Pneumonia killed 920,000 children worldwide in 2015, according to the World Health Organization.